RAND Q1 2026 Earnings Reported EPS of 018 Stock Falls 313 Praxis Precision Medicines Inc PRAX Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Despite No Revenue PHG Q1 2026 Earnings EPS Surprise Lifts but Stock Weakness Raises Caution FNV Q1 2026 Earnings EPS Surpasses Estimates by 137 as Royalty Portfolio Delivers DORM Q1 2026 Earnings Earnings Miss Estimates Stock Edges Lower BVN Q4 2025 Earnings Strong EPS Surprise Driven by Operational Gains